Approval times and the safety of new pharmaceuticals
Year of publication: |
2004
|
---|---|
Authors: | Rudholm, Niklas |
Published in: |
The European Journal of Health Economics. - Springer. - Vol. 5.2004, 4, p. 345-350
|
Publisher: |
Springer |
Subject: | Pharmaceutical markets | Approval times | Adverse drug reactions |
-
Innovation, loyalty and generic competition in pharmaceutical markets
AntoƱanzas, Fernando, (2011)
-
Prescribing Behavior of General Practitioners : Competition Matters!
Schaumans, C.B.C., (2014)
-
Prescribing Behavior of General Practitioners : Competition Matters!
Schaumans, C.B.C., (2014)
- More ...
-
Consumer Information and Pharmaceutical Prices: Theory and Evidence
Granlund, David, (2007)
-
Deregulating the Norwegian Pharmaceuticals Market - Consequences for Costs and Availability
Rudholm, Niklas, (2007)
-
Firm entry in the Swedish wholesale trade sector: Does market definition matter?
Brandt, Daniel, (2014)
- More ...